USP 797 doesn't change with vial size The procedural rules under United States Pharmacopeia General Chapter 797 apply identically whether the vial is 10 mg, 20 mg, or 30 mg: Preparation inside an ISO Class 5 primary engineering control That hood inside an ISO Class 7 cleanroom buffer area Gowning sequence and antiseptic hand cleansing before entry Sterile 70% isopropyl alcohol disinfection of vial septa Single-use sterile syringes, needles, and filter needles Documentation of lot numbers, beyond-use dates, and pharmacist signatures What changes with vial size is the number of weekly doses the preparation will support, which affects beyond-use date assignment and the cumulative number of septum punctures
These pharmacies are licensed, but heres the key thing: compounded medications are not FDA-approved
It is therefore recommended that administration of the oral formulation of semaglutide should be in the fasting state [27,28,29]
Never inject into a lumpy area, absorption from these sites is unpredictable
For most patients, appetite returns within 24 weeks of stopping